Thyroid-associated orbitopathy.
Tarabishy
Ahmad B
AB
Lewis
Criag D
CD
Perry
Julian D
JD
D000911:Antibodies, Monoclonal / Q000008:administration & dosage* / Q000009:adverse effects; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20 / Q000276:immunology; D001402:B-Lymphocytes / Q000187:drug effects; D004351:Drug Resistance; D005094:Exophthalmos / Q000175:diagnosis / Q000503:physiopathology; D005434:Flow Cytometry; D005938:Glucocorticoids / Q000627:therapeutic use*; D049970:Graves Ophthalmopathy / Q000188:drug therapy* / Q000276:immunology / Q000503:physiopathology; D006801:Humans; D007124:Immunoenzyme Techniques; D007155:Immunologic Factors / Q000008:administration & dosage* / Q000009:adverse effects; D007262:Infusions, Intravenous; D018655:Lymphocyte Count; D008212:Lymphocyte Depletion; D009915:Orbit / Q000378:metabolism / Q000473:pathology; D000069283:Rituximab; D013285:Strabismus / Q000175:diagnosis / Q000503:physiopathology; D050378:T-Lymphocytes, Regulatory / Q000276:immunology
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20; D005938:Glucocorticoids; D007155:Immunologic Factors; D000069283:Rituximab